- Home
- ERAS vs YSG Comparison
ERAS vs YSG Comparison
Compare ERAS & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- YSG
- Stock Information
- Founded
- ERAS 2018
- YSG 2016
- Country
- ERAS United States
- YSG China
- Employees
- ERAS N/A
- YSG N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- YSG Package Goods/Cosmetics
- Sector
- ERAS Health Care
- YSG Consumer Discretionary
- Exchange
- ERAS Nasdaq
- YSG Nasdaq
- Market Cap
- ERAS 432.6M
- YSG 362.5M
- IPO Year
- ERAS 2021
- YSG 2020
- Fundamental
- Price
- ERAS $1.16
- YSG $3.98
- Analyst Decision
- ERAS Strong Buy
- YSG
- Analyst Count
- ERAS 6
- YSG 0
- Target Price
- ERAS $4.83
- YSG N/A
- AVG Volume (30 Days)
- ERAS 2.3M
- YSG 162.0K
- Earning Date
- ERAS 05-07-2025
- YSG 05-21-2025
- Dividend Yield
- ERAS N/A
- YSG N/A
- EPS Growth
- ERAS N/A
- YSG N/A
- EPS
- ERAS N/A
- YSG N/A
- Revenue
- ERAS N/A
- YSG $464,908,550.00
- Revenue This Year
- ERAS N/A
- YSG $16.55
- Revenue Next Year
- ERAS N/A
- YSG $13.17
- P/E Ratio
- ERAS N/A
- YSG N/A
- Revenue Growth
- ERAS N/A
- YSG N/A
- 52 Week Low
- ERAS $1.01
- YSG $2.60
- 52 Week High
- ERAS $3.45
- YSG $6.13
- Technical
- Relative Strength Index (RSI)
- ERAS 41.47
- YSG 45.88
- Support Level
- ERAS $1.01
- YSG $3.42
- Resistance Level
- ERAS $1.29
- YSG $4.23
- Average True Range (ATR)
- ERAS 0.17
- YSG 0.39
- MACD
- ERAS 0.00
- YSG -0.08
- Stochastic Oscillator
- ERAS 31.25
- YSG 32.00
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The Group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.